THE ROLE OF GENETIC DETERMINANTS AND DISORDERS IN SYSTEMIC AND LOCAL IMMUNITY IN THE ETIOLOGY AND PATHOGENESIS OF HERPETIC ECZEMA (KAPOSI'S ECZEMA)
https://doi.org/10.22627/2072-8107-2016-15-3-42-45
Abstract
This review presents an analysis of the literature data on the etiology and pathogenesis of Herpetic Eczema (Kaposi's Eczema). Modern views on the complex genetic and phenotypic determinants of disease, reflecting the complex interactions between the skin and the immune system. Along with the general regularities characteristic of Herpetic Eczema in sufficient detail the reasons of infringements of functioning of the epidermal skin barrier, which contribute to an easier penetration of the Herpes Simplex Virus in the skin and its binding to cellular receptors in the implementation of the infectious process. The effect of systemic and local immunity, namely, changes in T-cell and interferon system in the development of the pathological process.
About the Authors
A. S. Stadnikova
Moscow Scientific-Practical Center of dermatology and cosmetology, Moscow
Russian Federation
Russian Federation
O. B Tamrazova
Russian University of Peoples' Friendship; Children's City Clinical Hospital them Z.A. Bashlyaevoy, Moscow
Russian Federation
Russian Federation
T. A. Chebotareva
Russian Medical Academy of Postgraduate Education of the Ministry of Health of Russia, Moscow
Russian Federation
Russian Federation
Chebotarevа Tatiana — DMS, Professor, Department of Pediatric Infectious Diseases
References
1. Herpes simplex: clinical and therapeutic aspects] // Medical Bulletin. Portal Russian Doctor. 2014; 4. (In Russ.)
2. Haldin A.A., Baskakovа D.V. [Epidemiological aspects of diseases caused by the herpes simplex virus (review)] // Dermatology. Supplement to the Consilium Medicum. 2007; 01: 27—30. (In Russ.)
3. Looker K.J., Garnett G.P. A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2 // Sex Transm Infect. 2005;81(2):103—107.
4. Kruglova L.S. [Atopic dermatitis and impaired-colonial resistance vzaimovyaz bowel and correction methods] // RussMedJr, 2011; 28: 1786—1790. (In Russ.)
5. Fitzpatrick J.E., Aeling J.L. Dermatology Secrets in Color. 2nd ed. — Philadelphia: Hanley Belfus. 2001.
6. Benedetto A., Agnihothri R., Bankova L., Beck L. Atopic Dermatitis: A Disease Caused by Innate Immune Defects? // Journal of Investigative Dermatology. 2009;129:14—30.
7. Leung D.Y. Why is eczema herpeticum unexpectedly rare? // Antiviral Res. 2013;98(2):153—7.
8. Broccardo C.J., Mahaffey S., Schwarz J., Wruck L., David G., Schlievert P.M., Reisdorph N.A., Leung D.Y. Comparative proteomic profiling of patients with atopic dermatitis based on history of eczema herpeticum infection and Staphylococcus aureus colonization // J Allergy Clin Immunol. 2011;127(1):186—93.
9. Gao P.S., Rafaels N.M., Hand T. et al. Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum // J Allergy Clin Immunol. 2009;124(3):507—13.
10. De Benedetto A., Slifka M.K., Rafaels N.M., Kuo I.H., Georas S.N., Boguniewicz M. et al. Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitis // J Allergy Clin Immunol. 2011;128(1):242—246.
11. Bin L., Howell M.D., Kim B.E., Streib J.E., Hall C.F., Leung D.Y. Spe cificity protein 1 is pivotal in the skin's antiviral response // J Allergy Clin Immunol. 2011;127(2):430—438.
12. Bin L., Kim B., Hall C., Leung D. Inhibition of Transcription Factor Specificity Protein 1 Alters the Gene Expression Profile of Keratinocytes Leading to Upregulation of Kallikrein-Related Peptidases and Thymic Stromal Lymphopoietin // Journal of Investigative Dermatology. 2011;131:2213—2222.
13. Min Z., Gnann J.W. Kaposi's varicelliform eruption // Jr.Intern Emerg Med. 2014;9(1):101—2.
14. De Guzman Strong C., Wertz P.W., Wang C., Yang F., Meltzer P.S., Andl T., Millar S.E., Ho I.C., Pai S.Y., Segre J.A. Lipid defect underlies selective skin barrier impairment of an epidermal-specific deletion of Gata-3 // J Cell Biol. 2006;175(4):661—70.
15. Liaw F., Huang C., Hsueh J., Chiang C. Eczema herpeticum: a medical emergency // Can Fam Physician. 2012;58(12):1358—61.
16. Gong J., Lin L., Lin T., Hao F., Zeng F., Bi Z. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial // Br J Dermatol. 2006;155:680—687.
17. Bin L., Kim B.E., Brauweiler A., Goleva E., Streib J., Ji Y., Schlievert P.M., Leung D.Y. Staphylococcus aureus -toxin modulates skin host response to viral infection // J Allergy Clin Immunol. 2012; 130(3):683—691.
18. Beck L.A., Boguniewicz M., Hata T., Schneider L.C., Hanifin J., Gallo R. et al. Phenotype of atopic dermatitis subjects with a history of eczema herpeticum // J Allergy Clin Immunol. 2009;124:260—269.
19. Albanesi C., Fairchild H.R., Madonna S. et al. IL-4 and IL-13 negatively regulate TNF-alphaand IFN-gamma-induced beta-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3 // J Immunol. 2007;179:984—92.
20. Kim B.E., Leung D.Y., Boguniewicz M. et al. Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6 // Clin Immunol. 2008;126:332—7.
21. Howell M.D., Gao P., Kim B.E., Lesley L.J., Streib J.E., Taylor P.A. The signal transducer and activator of transcription 6 gene (STAT6) increases the propensity of patients with atopic dermatitis toward disseminated viral skin infections // J Allergy Clin Immunol. 2011; 128(5):1006—14.
22. Rinaldo C.R., Torpey D.J. Cell-mediated immunity and immunosuppression in herpes simplex virus infection // Immunodeficiency. 1993;5(1):33—90.
23. Peng W.M., Jenneck C., Bussmann C., Bogdanow M., Hart J., Leung D.Y. et al. Risk factors of atopic dermatitis patients for eczema herpeticum // J Invest Dermatol. 2007;127:1261—1263.
24. Lee J., Ho W.H., Maruoka M. et al. (2001) IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1 // J Biol Chem 276:1660—4
25. Byung K., Lianghua B., Young-Min Y., Preveen R. and Donald Y. IL-25 Enhances HSV-1 Replication by Inhibiting Filaggrin Expression, and Acts Synergistically with Th2 Cytokines to Enhance HSV-1 Replication // Journal of Investigative Dermatology. 2013; 133:2678—2685.
26. Hanifin J.M., Thurston M., Omoto M., Cherill R., Tofte S.J., Graeber M. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group // Exp Dermatol. 2001; 10:11—18.
27. Tamrazova O.B., Mazankova L.N., Korsunskaya I.M., Pavlova L.A. [Herpetic eczema in children]: Guidelines. — Moscow, 2007. (In Russ.)
Review
For citations:
Stadnikova A.S., Tamrazova O.B., Chebotareva T.A. THE ROLE OF GENETIC DETERMINANTS AND DISORDERS IN SYSTEMIC AND LOCAL IMMUNITY IN THE ETIOLOGY AND PATHOGENESIS OF HERPETIC ECZEMA (KAPOSI'S ECZEMA). CHILDREN INFECTIONS. 2016;15(3):42-45. (In Russ.) https://doi.org/10.22627/2072-8107-2016-15-3-42-45
Views:
1011
Email this article 